A phase I dose-escalation study to assess the oncolytic virus VCN-01 safety and efficacy in refractory retinoblastoma patients.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jaume Català-Mora, Jaume Mora, Margarida Simao, Francis Munier, Livia Romero, Ligia Fu, Jesus Ardila, Ida Russo, Karina Senyase Zamarripa, Jesús Díaz-Cascajosa, Eduard Pedemonte-Sarrias, Marina Barraso-Rodrigo, Itziar Alonso Colmenero, Dolors Molies-Navarrete, Ana Mato-Berciano, Carmen Blasco, Manel Cascallo, Guillermo L. Chantada, Ángel Montero-Carcaboso
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410804752